Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cytology
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Cytology Articles & Analysis

29 news found

Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

As part of the collaboration, Tethis has placed one of its automated See.d instruments in the Cristofanilli lab, and the lab will use the instrument to isolate plasma and prepare cytology slides containing cells, including circulating tumor cells, from the blood. ...

ByTethis S.p.A


Alfa Cytology Launches Full-Scale Preclinical Services for Pancreatic Cancer Research   

Alfa Cytology Launches Full-Scale Preclinical Services for Pancreatic Cancer Research  

Through our neoantigen research service, Alfa Cytology identifies unique cancer-carrying genes by sequencing tumor cell genes to predict immune presentation affinity. ...

ByAlfa Cytology


Infrared Coagulation of The Inferior Turbinate: A new treatment for refractory chronic rhinitis

Infrared Coagulation of The Inferior Turbinate: A new treatment for refractory chronic rhinitis

CR is either infective or noninfective in origin, on the basis of the presence or respective absence of more than five polymorph leukocytes per high-power field (HPF) by nasal cytology." Infective CR is usually caused by sinusitis, whereas 48% of noninfective CR (NICR) is allergic (ACR), 15% nonallergic eosinophilic (NAECR), and 37% vasomotor (VMCR) in origin.2 The estimated ...

ByRedfield Corporation


Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly Improved

Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly Improved

Furthermore, as with earlier versions, this assay is performed using fresh FNA samples or diagnostic cytology slides, eliminating the need for an additional biopsy, refrigerated storage, or special ...

ByInterpace Biosciences


Former Roche Diagnostics NAM CEO Michael Tillmann joins X-ZELL executive board

Former Roche Diagnostics NAM CEO Michael Tillmann joins X-ZELL executive board

Atypical cells are the universal language of cancer diagnostics and commonly found in tissue or fluid samples that were surgically collected from the suspected site. By enabling cytology centres worldwide to detect atypical cells in non-invasive sample material and process them digitally at a new level of detail, we make highly accurate, non-invasive diagnostics accessible at ...

ByX-Zell Inc.


Interpace Biosciences Announces Second Quarter 2022 Financial and Business Results and New Clinical Validation Data; Diagnostic Accuracy Significantly Improved

Interpace Biosciences Announces Second Quarter 2022 Financial and Business Results and New Clinical Validation Data; Diagnostic Accuracy Significantly Improved

Furthermore, as with earlier versions, this assay is performed using fresh FNA samples or diagnostic cytology slides, eliminating the need for an additional biopsy, refrigerated storage, or special ...

ByInterpace Biosciences


Amerigo Scientific Launches Anex® Brush for Optimal Sampling

Amerigo Scientific Launches Anex® Brush for Optimal Sampling

At Amerigo Scientific, representative sample can be processed with conventional as well as liquid-based cytology (LBC) and also be used for bacteriological testing, virus testing, and DNA analysis. ...

ByAmerigo Scientific


Affimed Highlights Trial Designs of Three AFM24 Ongoing Clinical Studies at the Annual Meeting of the American Society of Clinical Oncology (ASCO)

Affimed Highlights Trial Designs of Three AFM24 Ongoing Clinical Studies at the Annual Meeting of the American Society of Clinical Oncology (ASCO)

Eligible patients must have positive histological or cytological staining of EGFR in >1% of tumor cells. The primary endpoint of the study is to establish the overall response rate in three disease-specific cohorts. ...

ByAffimed GmbH


OncoDNA and Synlab Partner to Facilitate Access to Comprehensive Biomarker Testing for Cancer Therapy Selection in Germany

OncoDNA and Synlab Partner to Facilitate Access to Comprehensive Biomarker Testing for Cancer Therapy Selection in Germany

Christian Mayer, head of human genetics, pathology and cytology at SYNLAB Germany, underlines the innovative advancement of the new test: “OncoDEEP is a real asset for oncology diagnostics offering in Germany. ...

ByOncoDNA S.A.


4D Path, PathPresenter Announce Partnership to Advance AI-enabled Digital Pathology for End-to-End Breast Tumor Profiling

4D Path, PathPresenter Announce Partnership to Advance AI-enabled Digital Pathology for End-to-End Breast Tumor Profiling

About 4D Path 4D Path’s mission is to democratize precision diagnostics and oncology by unveiling previously hidden information purely from cellular snapshots of tissue (e.g., histology) or liquid (e.g., cytology) without the use of antibody stains. The company’s cloud-based 4D Q-Plasia OncoReader (QPOR) is a U.S. patented pan-cancer precision diagnostic and oncology ...

By4D Path Inc.


QIAsure Methylation Test can decrease clinically non relevant colposcopy referrals of hpv positive women with asc-us/ lsil cytology

QIAsure Methylation Test can decrease clinically non relevant colposcopy referrals of hpv positive women with asc-us/ lsil cytology

British Journal of Cancer; https://doi.org/10.1038/s41416-021-01614-4 Primary HPV screening has doubled the number of colposcopy referrals because of direct referral of HPV-positive women with ASC-US/ LSIL cytology. This study evaluated the CIN3+ risks and colposcopy referrals by QIAsure Methylation Test analysis HPV16/18 genotyping HPV16/18/31/33/45 genotyping in ...

BySelf-screen B.V.


X-ZELL appoints Sebastian Grote as Managing Director

X-ZELL appoints Sebastian Grote as Managing Director

Atypical cells are the universal language of cancer diagnostics and commonly found in tissue or fluid samples that were surgically collected from the suspected site. By enabling cytology centres worldwide to detect atypical cells in non-invasive sample material and process them digitally at a new level of detail, we make highly accurate, non-invasive diagnostics accessible at ...

ByX-Zell Inc.


4D Path Expands with Multiple New Hires to Support Continued Development of Company’s Pan-Cancer Diagnostic and Precision Oncology Platform

4D Path Expands with Multiple New Hires to Support Continued Development of Company’s Pan-Cancer Diagnostic and Precision Oncology Platform

Lewent – Former Executive Vice President & Chief Financial Officer, Merck & Co. 4D Path Boilerplate Just because you can’t see something, doesn’t mean it’s not there. 4D Path’s mission is to democratize Precision Diagnostics and Oncology by unveiling previously hidden information purely from cellular snapshots of tissue (e.g., histology) or liquid (e.g., ...

By4D Path Inc.


Circulating atypical cells detected in blood of lung cancer patients

Circulating atypical cells detected in blood of lung cancer patients

New study data presented at the European Congress of Cytology – held from 3-6 Oct in Warsaw, Poland – confirmed that X-ZELL is able to detect tumour-associated circulating atypical cells in the blood of lung cancer patients The dataset comprised interim results from a pilot study carried out in Thailand by X-ZELL and Dr Kittipong Maneechotesuwan from Mahidol ...

ByX-Zell Inc.


X-ZELL hMX technology now available for research use

X-ZELL hMX technology now available for research use

“In combination with the Cryoimmunostaining™ Suite premiered in 2019 it will make for one of the most powerful cytology tools in the world.” According to Bhakdi, the first generation of the hMX™ Cell Separator will be exclusively offered in combination with the Cryoimmunostaining™ Suite.1 1Unless otherwise stated, X-ZELL products and services are ...

ByX-Zell Inc.


Dr. Craig Bunnell Joins Advisory Board of Cancer Diagnostic and Precision Oncology Platform Developer 4D Path

Dr. Craig Bunnell Joins Advisory Board of Cancer Diagnostic and Precision Oncology Platform Developer 4D Path

He received his MBA from the Massachusetts Institute of Technology in 2008. 4D Path Boilerplate Just because you can’t see something, doesn’t mean it’s not there. 4D Path’s mission is to democratize Precision Diagnostics and Oncology by unveiling previously hidden information purely from cellular snapshots of tissue (e.g., histology) or liquid (e.g., ...

By4D Path Inc.


Nucleix Presents Clinical Data at EAU21 Virtual Congress Which Demonstrates Promising Advances in the Care of Bladder Cancer Patients

Nucleix Presents Clinical Data at EAU21 Virtual Congress Which Demonstrates Promising Advances in the Care of Bladder Cancer Patients

The first abstract titled, “Real world evidence of alternating cystoscopy/cytology with Bladder EpiCheck in NMIBC surveillance,” shows the results of a pilot performed at Radboud University Medical Center evaluating the feasibility and clinical outcomes of alternating between cystoscopy/cytology and Bladder EpiCheck in non-muscle invasive bladder ...

ByNucleix Ltd.


Eurogin QIAGEN symposium

Eurogin QIAGEN symposium

Jesper Bonde (Hvidore Hospital, Denmark) – an extensive presentation of QIAsure Methylation Test performance and study data and its advantages as an alternative for cytology based triage strategies . Topic 2 June 2021: Evaluation of managing CIN 3+ diagnosed pregnant women by methylation assessment using FAM19A4 / miR124 methylation test Presenter: Prof. dr. ...

BySelf-screen B.V.


OncoDiag raises €2.5M ($3M) to develop its diagnostic testing for early detection of cancer

OncoDiag raises €2.5M ($3M) to develop its diagnostic testing for early detection of cancer

It also offers an alternative to urine cytology and may reduce or even replace highly invasive examinations such as cystoscopies. ...

ByOncoDiag


The Netherlands started QIAsure Methylation Test implementation trial for triage of HPV positively screened women

The Netherlands started QIAsure Methylation Test implementation trial for triage of HPV positively screened women

More women at risk are being discovered due to the higher sensitivity of HPV assays compared to the old cytology based test program, but as a consequence the number of referrals after cytology based triage of HPV positive women has increased 3 times. The majority of these referrals appear unnecessary because the HPV positive cytology positive ...

BySelf-screen B.V.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT